The Evolution of Lenacapavir in HIV Treatment
Published: July 24th 2024 | Updated: July 25th 2024The antiviral began its development as a multidrug-resistant therapy for people with HIV, and has since been studied as PrEP intervention, with many now calling for it to be made widely available for mass distribution.
Read More
CDC Updated COVID-19 and Influenza Vaccination Guidelines for 2024-2025 Season
June 27th 2024During today's CDC Advisory Committee on Immunization Practices (ACIP) meeting, committee members voted to recommend the FDA-authorized 2024-2025 COVID-19 vaccines for individuals aged 6 months and older. Additionally, they reaffirmed the existing influenza vaccination guidelines for the 2024-2025 season.
Read More
BRII-179 Data Unveils Promising Insights for Chronic Hepatitis B Treatment
June 11th 2024Brii Biosciences presented new data from Phase 2 trials for chronic hepatitis B at EASL Congress 2024, revealing insights into the efficacy of BRII-179 as botha combined therapy and an additional treatment.
Read More
Impact of Live Biotherapeutic Products on Gut Microbiome in Recurrent C difficile Infections
June 11th 2024Presented at DDW 2024 by Ken Blount, the effectiveness of live biotherapeutic products in treating recurrent C difficile infections (rCDI), offering insights into microbiota alteration and prospects for management.
Read More
Efficacy of Fecal Microbiota Therapy for Recurrent Clostridioides difficile Infection
May 21st 2024At Digestive Disease Week, Paul Feuerstadt MD, FACG, AGAF and fellow investigators explore the potential impact of non-antibiotic medications on gut health and their association with recurrent CDI.
Watch
Increased Healthcare-Associated Infections: The COVID-19 Impact on Hospital Infection Prevention
April 22nd 2024Monika Pogorzelska-Maziarz, epidemiologist, health services researcher, and associate professor at Thomas Jefferson University, shares insights on COVID-19's influence in acute care hospitals at this year’s Society for Healthcare Epidemiology of America (SHEA) conference.
Watch
Study Reveals Transmission of Candida auris from Adults to Children in Maryland Hospital
April 17th 2024The results were presented at the Society for Healthcare Epidemiology of America (SHEA) conference, highlighting this first documented case of C auris moving from an adult to a pediatric unit within the state.
Read More
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration
April 17th 2024A study, presented at the Society for Healthcare Epidemiology of America (SHEA) conference, assesses laxative administration before CDI testing in Veteran Affairs (VA) hospitals and explores the demographic and contextual factors with non-adherence to guidelines.
Read More
This year at the Conference on Retroviruses and Opportunistic Infections (CROI), Lenacapavir shows virological suppression, Remdesivir reduces long covid risks, Bulevirtide benefits chronic HBV, HIV treatment enhances outcomes, vaginal ring or oral pre-exposure prophylaxis safe for HIV prevention throughout pregnancy.
Read More